Cardiocore Launches New Web site
Cardiocore announced the launch of its redesigned corporate Web site that provides users with a comprehensive view of Cardiocore's history as a top-quality, innovative core lab.
Celebrating the New Year, Cardiocore Launches a New Web Site
Site Highlights Core Lab’s Leadership in Service, Science and Data Management
Washington, DC—Cardiocore, a premier centralized cardiac testing lab, announced the launch of its redesigned corporate web site at http://www.cardiocore.com. The company’s new Internet presence provides users with a comprehensive view of Cardiocore’s history as a top-quality, innovative core lab.
“The new site delivers insights to Cardiocore’s leadership in global service, expert science and advanced data management,” said Cardiocore Vice President of Sales, Robert Goodman. He continued, “Visitors may easily find useful information about Cardiocore’s offerings such as ECG, Holter, ECHO and MUGA analyses, as well as protocol development, scientific reporting and statistics.”
Founded by a cardiac research expert and led by a clinical data management veteran, Cardiocore is often recognized as an innovator in the application of cardiac data technology. Focusing on that differentiator, Cardiocore Vice President of Marketing, Scott Satin noted, “The new site offers details about sponsor-benefiting technologies such as CardioPortal™—the company’s advanced web-based data delivery service, and HolterGateway™—Cardiocore’s leading-edge Holter data transfer system.” He added, “The new home page includes a link for direct login to CardioPortal by customers and clinical site personnel around the world.”
The newly launched web site also provides sponsors and investigators rapid access to experienced professionals located at Cardiocore’s three office locations. The company’s global headquarters is located outside Washington, DC, its US West Coast operation is in San Francisco, CA, and its European operation is based in London, UK.
About Cardiocore: Cardiocore has provided superior centralized cardiac testing services to the pharmaceutical industry for 16 years. Services include centralized electrocardiography (ECG), Holter, echocardiography (ECHO), multigated acquisition scans (MUGA), and consulting services such as protocol development, scientific reporting and statistical analyses. The company is experienced in the design and the implementation of cardiac safety and efficacy testing in Phase I-IV and Thorough QT clinical trials. These services are supported by the company’s advanced data management system featuring the proprietary HolterGateway™ and CardioPortal™. Cardiocore’s U.S. headquarters is located in Bethesda, Maryland, its West Coast office is located in San Francisco, California, and its European subsidiary, Cardiocore Limited, is located in London, England. www.cardiocore.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
